OMNI Kudos to CSBs/Agencies with SOR III Intake Target Completion!

OMNI Kudos to CSBs/Agencies Meeting Their SOR III FY22-23 Intake GPRA Target Numbers!

We are continuing to share some kudos about CSBs or Agencies that are doing well with intakes, follow-ups, engaging and supporting clients, and/or those that demonstrate a "spirit of inquiry" when engaging with our TA Team on GPRA administration issues.

This month, we’d like to share kudos for numerous CSBs and Agencies for meeting their SOR III Year 1 intake target! We are about 85% of the way through Year 1 and the following 18 CSBs and Agencies have all reached at least 100% or more of their intake targets. Kudos!

CSBs/Agencies

  • Alexandria

  • Alleghany Highlands

  • Arlington

  • Caritas

  • Chesapeake Opioid IOP CCAP

  • Goochland-Powhatan

  • Highlands

  • Loudoun

  • Middle Peninsula Northern Neck

  • New River Valley

  • Norfolk

  • Northwestern

  • Piedmont

  • Planning District 1

  • Portsmouth

  • Prince William

  • Southside CSB

  • Valley

We know that everyone is working hard toward meeting their intake target as set out by DBHDS this year. Please pay close attention to your tracking sheet and schedule your Follow-up GPRA interviews accordingly.

The TA Team is available to help if you have questions about any aspect of GPRA administration or would like any tips on best practices. If so, please reach out to our team at SORsupport@omni.org

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.